Trades on 2 secondary markets

ROME Therapeutics

Rome Therapeutics is a Cambridge, Massachusetts biotechnology company developing therapies that target the "repeatome" — the vast repetitive, non-coding regions of the human genome (the "dark genome," including LINE-1 and other transposable elements) implicated in cancer and autoimmune disease. Its

minimal 8.1 / 100 0 APIs View provider profile →

Company Biotechnology Genomics Drug Discovery Oncology Autoimmune

ROME Therapeutics is an API provider whose private shares are listed on 2 secondary markets: Forge Global, EquityZen.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.